Upregulating CD4+CD25+FOXP3+ regulatory T cells in pancreatic lymph nodes in diabetic NOD mice by adjuvant immunotherapy

Transplantation

Volumn 87, Issue 2, 2009, Pages 198-206

  Tian, Bole ^a,b   Hao, Jianqiang ^a   Zhang, Yu ^a   Tian, Lei ^a   Yi, Huimin ^a   O'Brien, Timothy D ^c   Sutherland, David E R ^a   Hering, Bernhard J ^a   Guo, Zhiguang ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b SICHUAN UNIVERSITY   (China)

^c UNIVERSITY OF MINNESOTA   (United States)

Author keywords

Autoimmunity; NOD mice; Regulatory T cells; Tolerance; Type 1 diabetes

Indexed keywords

CD4 ANTIGEN; EXENDIN 4; FREUND ADJUVANT; GLUCAGON LIKE PEPTIDE 1; GLUCOSE; INSULIN; INTERLEUKIN 2 RECEPTOR ALPHA; TRANSCRIPTION FACTOR FOXP3; TRANSFORMING GROWTH FACTOR BETA1; ANTIDIABETIC AGENT; FORKHEAD TRANSCRIPTION FACTOR; FOXP3 PROTEIN, MOUSE; IL2RA PROTEIN, MOUSE; IMMUNOLOGICAL ADJUVANT; PEPTIDE; VENOM;

ADOPTIVE TRANSFER; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOIMMUNITY; CELL DIVISION; CONTROLLED STUDY; DIABETES MELLITUS; DRUG POTENTIATION; FEMALE; GLUCOSE BLOOD LEVEL; IMMUNOHISTOCHEMISTRY; IMMUNOREGULATION; IMMUNOTHERAPY; LYMPH NODE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; SINGLE DRUG DOSE; SPLEEN CELL; UPREGULATION; ANIMAL; BLOOD; CD4+ T LYMPHOCYTE; CELL PROLIFERATION; DISEASE MODEL; DRUG COMBINATION; DRUG EFFECT; IMMUNOLOGY; INSULIN DEPENDENT DIABETES MELLITUS; METABOLISM; MOUSE MUTANT; NONOBESE DIABETIC MOUSE; PANCREAS; PANCREAS ISLET BETA CELL; TIME; TRANSPLANTATION;

ADJUVANTS, IMMUNOLOGIC; ADOPTIVE TRANSFER; ANIMALS; AUTOIMMUNITY; BLOOD GLUCOSE; CD4-POSITIVE T-LYMPHOCYTES; CELL PROLIFERATION; DIABETES MELLITUS, TYPE 1; DISEASE MODELS, ANIMAL; DRUG THERAPY, COMBINATION; FEMALE; FORKHEAD TRANSCRIPTION FACTORS; FREUND'S ADJUVANT; HYPOGLYCEMIC AGENTS; INSULIN; INSULIN-SECRETING CELLS; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; LYMPH NODES; MALE; MICE; MICE, INBRED NOD; MICE, SCID; PANCREAS; PEPTIDES; T-LYMPHOCYTES, REGULATORY; TIME FACTORS; TRANSFORMING GROWTH FACTOR BETA1; UP-REGULATION; VENOMS;

EID: 59649108624     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e3181933261     Document Type: Article

References (39)

1. Sadelain MW, Qin HY, Lauzon J, et al. Prevention of type I diabetes in NOD mice by adjuvant immunotherapy. Diabetes 1990; 39: 583.
2. McInerney MF, Pek SB, Thomas DW. Prevention of insulitis and diabetes onset by treatment with complete Freund's adjuvant in NOD mice. Diabetes 1991; 40: 715.
3. Sadelain MW, Qin HY, Sumoski W, et al. Prevention of diabetes in the BB rat by early immunotherapy using Freund's adjuvant. J Autoimmun 1990; 3: 671.
4. Wang T, Singh B, Warnock GL, et al. Prevention of recurrence of IDDM in islet-transplanted diabetic NOD mice by adjuvant immunotherapy. Diabetes 1992; 41: 114.
5. Nishio J, Gaglia JL, Turvey SE, et al. Islet recovery and reversal of murine type 1 diabetes in the absence of any infused spleen cell contribution. Science 2006; 311: 1775.
6. Chong AS, Shen J, Tao J, et al. Reversal of diabetes in non-obese diabetic mice without spleen cell-derived beta cell regeneration. Science 2006; 311: 1774.
7. Suri A, Calderon B, Esparza TJ, et al. Immunological reversal of autoimmune diabetes without hematopoietic replacement of beta cells. Science 2006; 311: 1778.
8. Lee IF, Qin H, Trudeau J, et al. Regulation of autoimmune diabetes by complete Freund's adjuvant is mediated by NK cells. J Immunol 2004; 172: 937.
9. Qin HY, Chaturvedi P, Singh B. In vivo apoptosis of diabetogenic T cells in NOD mice by IFN-gamma/TNF-alpha. Int Immunol 2004; 16: 1723.
10. Shevach EM. Regulatory T cells in autoimmmunity*. Annu Rev Immunol 2000; 18: 423.
11. Sakaguchi S, Sakaguchi N. Regulatory T cells in immunologic self-tolerance and autoimmune disease. Int Rev Immunol 2005; 24: 211.
12. Sakaguchi S, Setoguchi R, Yagi H, et al. Naturally arising Foxp3-expressing CD25+CD4+ regulatory T cells in self-tolerance and autoimmune disease. Curr Top Microbiol Immunol 2006; 305: 51.
13. Kanagawa O, Militech A, Vaupel BA. Regulation of diabetes development by regulatory T cells in pancreatic islet antigen-specific TCR transgenic nonobese diabetic mice. J Immunol 2002; 168: 6159.
14. Tang Q, Henriksen KJ, Bi M, et al. In vitro-expanded antigen-specific regulatory T cells suppress autoimmune diabetes. J Exp Med 2004; 199: 1455.
15. Chen Z, Herman AE, Matos M, et al. Where CD4+CD25+ T reg cells impinge on autoimmune diabetes. J Exp Med 2005; 202: 1387.
16. Tang Q, Adams JY, Tooley AJ, et al. Visualizing regulatory T cell control of autoimmune responses in nonobese diabetic mice. Nat Immunol 2006; 7: 83.
17. Belghith M, Bluestone JA, Barriot S, et al. TGF-beta-dependent mechanisms mediate restoration of self-tolerance induced by antibodies to CD3 in overt autoimmune diabetes. Nat Med 2003; 9: 1202.
18. GreenEA, Gorelik L, McGregor CM, et al. CD4+CD25+ Tregulatory cells control anti-islet CD8+ T cells through TGF-beta-TGF-beta receptor interactions in type 1 diabetes. Proc Natl Acad Sci USA 2003; 100: 10878.
19. Peng Y, Laouar Y, Li MO, et al. TGF-beta regulates in vivo expansion of Foxp3-expressing CD4+CD25+ regulatory T cells responsible for protection against diabetes. Proc Natl Acad Sci USA 2004; 101: 4572.
20. Luo X, Yang H, Kim IS, et al. Systemic transforming growth factor-beta1 gene therapy induces Foxp3+ regulatory cells, restores self-tolerance, and facilitates regeneration of beta cell function in overtly diabetic nonobese diabetic mice. Transplantation 2005; 79: 1091.
21. Du W, Wong FS, Li MO, et al. TGF-beta signaling is required for the function of insulin-reactive T regulatory cells. J Clin Invest 2006; 116: 1360.
22. Kriegel MA, Li MO, Sanjabi S, et al. Transforming growth factor-beta: Recent advances on its role in immune tolerance. Curr Rheumatol Rep 2006; 8: 138.
23. Li MO, Wan YY, Sanjabi S, et al. Transforming growth factor-beta regulation of immune responses. Annu Rev Immunol 2006; 24: 99.
24. Baggio LL, Drucker DJ. Harnessing the therapeutic potential of glucagon-like peptide-1: A critical review. Treat Endocrinol 2002; 1: 117.
25. Brubaker PL, Drucker DJ. Minireview: Glucagon-like peptides regulate cell proliferation and apoptosis in the pancreas, gut, and central nervous system. Endocrinology 2004; 145: 2653.
26. Perfetti R, Zhou J, Doyle ME, et al. Glucagon-like peptide-1 induces cell proliferation and pancreatic-duodenum homeobox-1 expression and increases endocrine cell mass in the pancreas of old, glucose-intolerant rats. Endocrinology 2000; 141: 4600.
27. Hui H, Wright C, Perfetti R. Glucagon-like peptide 1 induces differentiation of islet duodenal homeobox-1-positive pancreatic ductal cells into insulin-secreting cells. Diabetes 2001; 50: 785.
28. De Leon DD, Deng S, Madani R, et al. Role of endogenous glucagon-like peptide-1 in islet regeneration after partial pancreatectomy. Diabetes 2003; 52: 365.
29. Xu G, Stoffers DA, Habener JF, et al. Exendin-4 stimulates both beta-cell replication and neogenesis, resulting in increased beta-cell mass and improved glucose tolerance in diabetic rats. Diabetes 1999; 48: 2270.
30. Tourrel C, Bailbe D, Meile MJ, et al. Glucagon-like peptide-1 and exendin-4 stimulate beta-cell neogenesis in streptozotocin-treated newborn rats resulting in persistently improved glucose homeostasis at adult age. Diabetes 2001; 50: 1562.
31. Brode S, Raine T, Zaccone P, et al. Cyclophosphamide-induced type-1 diabetes in the NOD mouse is associated with a reduction of CD4+CD25+Foxp3+ regulatory T cells. J Immunol 2006; 177: 6603.
32. Brusko T, Wasserfall C, McGrail K, et al. No alterations in the frequency of FOXP3+ regulatory T-cells in type 1 diabetes. Diabetes 2007; 56: 604.
33. Hadjiyanni I, Baggio LL, Poussier P, et al. Exendin-4 modulates diabetes onset in nonobese diabetic mice. Endocrinology 2008; 149: 1338.
34. Bonner-Weir S. Islet growth and development in the adult. J Mol Endocrinol 2000; 24: 297.
35. Bonner-Weir S. Beta-cell turnover: Its assessment and implications. Diabetes 2001; 50 (Suppl 1): S20.
36. Phillips JM, O'Reilly L, Bland C, et al. Patients with chronic pancreatitis have islet progenitor cells in their ducts, but reversal of overt diabetes in NOD mice by anti-CD3 shows no evidence for islet regeneration. Diabetes 2007; 56: 634.
37. Sherry NA, Kushner JA, Glandt M, et al. Effects of autoimmunity and immune therapy on beta-cell turnover in type 1 diabetes. Diabetes 2006; 55: 3238.
38. OgawaN, List JF, Habener JF, et al. Cure of overt diabetes in NOD mice by transient treatment with anti-lymphocyte serum and exendin-4. Diabetes 2004; 53: 1700.
39. Dor Y, Brown J, Martinez OI, et al. Adult pancreatic beta-cells are formed by self-duplication rather than stem-cell differentiation. Nature 2004; 429: 41.